Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent 2023-12-13 19:00
1